Toolkit/fluorescence recovery after photobleaching

fluorescence recovery after photobleaching

Assay Method·Research·Since 2026

Also known as: FRAP

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Fluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within the pathological condensate termed the addivosome. In this context, FRAP is intended to detect restoration of mobility, or reliquefaction, during compound screening.

Usefulness & Problems

Why this is useful

This assay is useful as a phenotypic readout for compounds that may reverse a pathological condensate state by restoring liquid-like molecular dynamics. The supplied evidence specifically positions FRAP as a screening endpoint for addivosome-targeting interventions.

Source:

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Problem solved

FRAP is proposed to address the problem of how to measure restoration of molecular mobility within the addivosome during compound screening. The evidence supports its use as a readout of reliquefaction rather than as a validated therapeutic screening platform.

Source:

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Problem links

Need better screening or enrichment leverage

Derived

Fluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.

Need conditional recombination or state switching

Derived

Fluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.

Need precise spatiotemporal control with light input

Derived

Fluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

recombinationselection

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: sensorreadout type: molecular mobility

The assay requires light input for photobleaching and fluorescence-based measurement of recovery, consistent with FRAP methodology. Beyond its proposed use as a readout for addivosome reliquefaction in compound screening, the supplied evidence does not specify construct design, instrumentation, cell system, or analysis workflow.

The evidence is limited to a proposal in a single source and does not provide experimental validation, quantitative performance metrics, or benchmarking against alternative assays. No details are supplied on fluorophores, imaging conditions, recovery models, throughput, or biological systems used for implementation.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 2method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 3method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 4method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 5method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 6method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 7method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 8method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 9method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 10method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 11method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 12method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 13method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 14method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 15method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 16method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 17method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 18method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 19method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 20method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 21method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 22method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 23method proposalsupports2026Source 1needs review

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Claim 24method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 25method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 26method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 27method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 28method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 29method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 30method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 31method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 32method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 33method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 34method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 35method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 36method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 37method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 38method proposalsupports2026Source 1needs review

Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.

Claim 39therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 40therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 41therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 42therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 43therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 44therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 45therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 46therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 47therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 48therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 49therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 50therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 51therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 52therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Claim 53therapeutic strategysupports2026Source 1needs review

Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.

Approval Evidence

2 sources2 linked approval claimsfirst-pass slug fluorescence-recovery-after-photobleaching
measured by fluorescence recovery after photobleaching

Source:

Diffusion of paracrine factors has been studied using techniques such as fluorescence recovery after photobleaching (FRAP).

Source:

method proposalsupports

Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.

Source:

tool usesupports

FCS, FRAP, FDAP, and single-molecule tracking are used to study diffusion of paracrine factors through extracellular space.

Source:

Comparisons

Source-backed strengths

The cited literature explicitly proposes FRAP as a direct functional readout of liquid-like molecular mobility in the addivosome context. Its conceptual strength here is that recovery after photobleaching can report changes in condensate material state during screening.

fluorescence recovery after photobleaching and droplet microfluidic platform address a similar problem space because they share recombination, selection.

Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light

Compared with FLIPR

fluorescence recovery after photobleaching and FLIPR address a similar problem space because they share recombination, selection.

Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light

fluorescence recovery after photobleaching and open-source microplate reader address a similar problem space because they share recombination, selection.

Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light

Ranked Citations

  1. 1.

    Extracted from this source document.